AA

Anti-Cancer Agents in Medicinal Chemistry

Anti-Cancer Agents in Medicinal Chemistry is a journal in cancer drug discovery and medicinal chemistry. It has ISSN 1871-5206 (Print) and 1875-5992 (Online), an impact factor of 3, and indexing in Scopus, SCI Expanded, and MEDLINE/PubMed. Open access articles are available, while the journal also offers subscription access.

Looking to publish in Anti-Cancer Agents in Medicinal Chemistry? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Existing customer login
Subject Oncology
Impact Factor 3
Quartile Q2
Open Access Type Open
ISSN 1871-5206
eISSN 1875-5992
Invitation Only No
Cost Range Publication costs are supported by an Article Processing Charge (APC), typically paid by the author's institution, funding body, or the authors themselves.

Submission Instructions

Anti-Cancer Agents in Medicinal Chemistry accepts the following article types. Click on an article type to view submission instructions.

Review Articles

Cover Letter A copyright letter must be submitted by the principal or corresponding author on behalf of all co-authors. The copyright letter must include confirmation from all contributing authors by signature and full responsibility for the manuscript contents.
Abstract A structured abstract is required. The abstract must be structured.
Manuscript Review articles should be 6000–10000 words. The manuscript must be organized into Title, Title page, Structured Abstract, Graphical Abstract, Keywords, Text Organization, Conclusion, List of Abbreviations (if any), Consent for Publication, Availability of Data and Materials, Funding, Conflict of Interest, Acknowledgements, References, Appendices, Figures/Illustrations (if any), Chemical Structures (if any), Tables (if any), and Supportive/Supplementary Material (if any). The manuscript must include a graphical abstract, 6 to 8 keywords, and declarations for funding, conflict of interest, acknowledgements, and authors' contribution, and any AI use for images, graphical elements, or data collection and analysis must be disclosed in the manuscript.
References Review articles should include 100 or more references. References should be submitted preferably in ACS, IEEE, or Vancouver style. References must be complete and accurate, cited in the text in square-bracketed numerical order where first discussed, and fully formatted before submission.
Figures & Tables There is no restriction on the number of figures, tables, or additional files that can be included online. Figures must be uploaded as separate files and embedded in the manuscript PDF, while tables must be embedded in the text according to appropriate placement. Figures and tables must be numbered consecutively in the order first cited in the text, and each table must include a self-explanatory title while each figure must have a legend or caption.
Reformat to Anti-Cancer Agents in Medicinal Chemistry using Livewrite Premium

Mini-Reviews

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract requirements are not specified.
Manuscript Mini-Reviews should be 3000–6000 words. The manuscript must include 6 to 8 keywords, a graphical abstract, a conflict of interest statement, and an Authors' Contribution paragraph.
References Mini-Reviews should include 75 or more references. References should preferably follow ACS, IEEE, or Vancouver style. References must be complete and accurate, cited in the text in square brackets where first discussed, and listed in finalized numerical order.
Figures & Tables There is no restriction on the number of figures, tables, or additional files that can be included online. Figures and tables must be embedded in the manuscript text according to their appropriate placement, although figure files must also be uploaded separately for online submission. Figures must be numbered consecutively with captions, and tables must be submitted in Microsoft Word table format with a self-explanatory title or caption.
Reformat to Anti-Cancer Agents in Medicinal Chemistry using Livewrite Premium

Systematic Reviews

Cover Letter A copyright letter must be submitted by the principal or corresponding author on behalf of all co-authors.
Abstract A structured abstract is required. Abstract must not exceed 250 words. Abstract must be structured with explicit subheadings. The abstract must include explicit subheadings, and the registration number of the registered systematic review must appear as the last line of the abstract.
Manuscript Systematic Reviews should be 4000–6000 words. Null The manuscript must include 6 to 8 keywords, a graphical abstract, conflict of interest and Authors' Contribution statements, and an AI-use disclosure in the Materials and Methods or similar section when applicable.
References Systematic Reviews should include 100 or more references. References should be submitted preferably in ACS, IEEE, or Vancouver style. References must be cited in the text using square-bracketed numbers in the order they are first discussed, and the reference list must be complete and fully formatted before submission.
Figures & Tables There is no restriction on the number of figures, tables, or additional files that can be included online. Figures and tables must be embedded in the manuscript text according to their appropriate placement, although figures and illustrations must also be uploaded as separate files for online submission. Each figure must contain a single illustration with a caption and be numbered consecutively, and each table must be in Microsoft Word table format with a self-explanatory caption and numbered sequentially.
Reformat to Anti-Cancer Agents in Medicinal Chemistry using Livewrite Premium

Meta-Analyses

Cover Letter A copyright letter must be submitted by the principal or corresponding author on behalf of all co-authors. The copyright letter must include signatures from all contributing authors with their full name, affiliation, email address, ORCID ID, and role in the article.
Abstract A structured abstract is required. The abstract must not exceed 250 words. The abstract must be structured with explicit subheadings. The abstract must include explicit subheadings.
Manuscript The manuscript must include 6 to 8 keywords, a separate Authors' Contribution paragraph, a conflict of interest statement before the references, and AI-use disclosure in the Materials and Methods or similar section when applicable.
References References should be submitted preferably in ACS, IEEE, or Vancouver style. References must be cited in the text in square brackets where first discussed and the bibliography must be complete, accurate, and fully formatted before submission.
Figures & Tables There is no restriction on the number of figures, tables, or additional files that can be included online. Illustrations and tables must be embedded in the manuscript according to their appropriate placement, while figures and illustrations must also be uploaded as separate files for online submission. Figures must be numbered consecutively with legends or captions, each figure should contain a single illustration with multipart figures combined into one file, and each table must include a self-explanatory title or caption.
Reformat to Anti-Cancer Agents in Medicinal Chemistry using Livewrite Premium

Research Articles

Cover Letter A copyright letter must be submitted by the principal or corresponding author on behalf of all co-authors. The copyright letter must include confirmation from all contributing authors with their signatures and full responsibility for the manuscript contents.
Abstract A structured abstract is required. The abstract must not exceed 250 words. The abstract must be structured with explicit subheadings. Explicit subheadings are required in the structured abstract.
Manuscript Research Articles should be 4000-6000 words. The manuscript must include the specified front matter and be organized with main text sections of Introduction, Materials and Methods, Results, Discussion, Conclusion, Ethics Approval and Consent to Participate, Human and Animal Rights, Conflict of Interest, Acknowledgements, and References. The manuscript must include a graphical abstract, 6 to 8 keywords, an Authors' Contribution paragraph, a conflict of interest statement, funding information, supportive/supplementary material section if applicable, and AI-use disclosure in the Materials and Methods or similar section when such tools were used.
References Research Articles should include 75 or more references. References should be submitted preferably in ACS, IEEE, or Vancouver style. References must be cited in the text using square-bracketed numbers at the appropriate place where they are first discussed and listed as a complete, fully formatted bibliography.
Figures & Tables There is no restriction on the number of figures, tables, or additional files that can be included online. Figures and tables must be embedded in the manuscript text according to their appropriate placement, while figure files must also be uploaded separately and a PDF with all items embedded must be included. Figures must be numbered consecutively with captions and each figure should contain a single illustration, while tables must be numbered sequentially and include a self-explanatory title or caption.
Reformat to Anti-Cancer Agents in Medicinal Chemistry using Livewrite Premium

Randomized Drug Clinical Trial Studies

Cover Letter Cover Letter requirements are not specified.
Abstract The abstract must end with the trial registry name, registration identification number, and registry URL.
Manuscript Randomized Drug Clinical Trial Studies should be 4000–6000 words. The manuscript must clearly state an objective or hypothesis, design and methods including study setting and dates, participants with inclusion and exclusion criteria or data sources and selection methods, essential features of interventions, main outcome measures, main results, a comment section addressing context and study limitations, conclusions, and a "Randomization and Masking" section within the Methods. The manuscript must include a flow diagram and state the trial registry name, registration identification number, and registry URL at the end of the abstract, and it must include AI-use disclosure in the Materials and Methods or similar section if such tools were used for images or graphical elements or for data collection or analysis.
References Randomized Drug Clinical Trial Studies should include 50 or more references. References should be submitted preferably in ACS, IEEE, or Vancouver style. References must be complete and accurate, cited in the text in square-bracketed numerical order where first discussed, and fully formatted before submission.
Figures & Tables There is no restriction on the number of figures or tables that can be included online. Figures and tables must be embedded in the manuscript according to their appropriate placement, although figure files must also be uploaded separately for online submission. Figure legends or captions are required, figures must be numbered consecutively in order of appearance with separate parts combined into a single composite illustration, and each table must have a self-explanatory title or caption and be numbered sequentially in Arabic numerals.
Reformat to Anti-Cancer Agents in Medicinal Chemistry using Livewrite Premium

Short Communications

Cover Letter A copyright letter must be submitted by the principal or corresponding author on behalf of all co-authors. The copyright letter must include signed confirmation from all contributing authors with their full name, affiliation, email address, ORCID ID, and role in the article.
Abstract Abstract requirements are not specified.
Manuscript Short Communications should be 2000–3000 words. The manuscript must include 6 to 8 keywords, a graphical abstract submitted separately, conflict of interest and authors' contribution statements, and AI-use disclosure if applicable.
References Short Communications should include 25 or more references. References should be submitted preferably in ACS, IEEE, or Vancouver style. References must be complete and accurate, numbered in square brackets in the text, and cited where they are first discussed.
Figures & Tables There is no restriction on the number of figures, tables, or additional files that can be included with each article online. Figures must be uploaded as separate files, while illustrations and tables must also be embedded in the manuscript text at their appropriate placement. Figures must be numbered consecutively and include legends, and tables must be numbered in Arabic numerals and include a self-explanatory title or caption.
Reformat to Anti-Cancer Agents in Medicinal Chemistry using Livewrite Premium

Recent Publications

QSAR Modeling of Camptothecin Derivatives Targeting Topoisomerase I: Structural Insights for Anticancer Drug Design

Hossam A. Mahmoud, Noha A. Elnady, Salma A. Elmallah

10.2174/0118715206389047251115115049
View Publication

Analysis of the Oncogenic Role of Colony-Stimulating Factor 1 Receptor (CSF1R) in Pancreatic Adenocarcinoma

Huiying Cui, Xuezhe Piao, Jiaming Zhang, Zhezhu Han, Qiang Xu

10.2174/0118715206464495260330052127
View Publication

Immunohistochemical Evaluation of PD-L1 Expression in Complex Atypical Hyperplasia and Early-Stage Endometrial Cancer

Levent Akman, Mert Acar, Gurdeniz Serin, Lena Tureyici, Nuri Yildirim, Osman Zekioglu, Burcak Karaca, Mustafa Cosan Terek

10.2174/0118715206478683260521063609
View Publication

Marine-Derived Dual BTK-FGFR Inhibitors: Pioneering a New Era of Precision Oncology Therapeutics

Sonam Kundral, Anoop Kumar, Puneet Gupta, Ramesh Bodla, Dharmendra Kumar

10.2174/0118715206464059260420095736
View Publication

Targeting CHCHD3 inhibits tumorigenesis of NSCLC by Reprogramming Mitochondrial Metabolism

Lili Jin, Jiahao Shen, Xuting Xu, Pingping Niu, Yu Zhou, Shunli Dong, Qibin Shen, Qinhua Gu

10.2174/0118715206469218260522055432
View Publication

Frequently asked questions

How long does it take to publish?

Revised manuscripts are usually requested within 15 days. Revision time may vary from one to four weeks depending on whether changes are minor or major. Proof corrections should be returned within 48 hours. Accepted papers may be published electronically ahead of scheduled publication.

Reformat to Anti-Cancer Agents in Medicinal Chemistry using Livewrite Premium

Is a cover letter required?

A signed copyright letter must be submitted by the corresponding author along with the manuscript on behalf of all co-authors.

Reformat to Anti-Cancer Agents in Medicinal Chemistry using Livewrite Premium

What are the publication costs?

Publication costs are supported by an Article Processing Charge (APC), typically paid by the author's institution, funding body, or the authors themselves.

Reformat to Anti-Cancer Agents in Medicinal Chemistry using Livewrite Premium

Research Topics

Synthesis and biological activity Cancer Mechanisms and Therapy Cancer therapeutics and mechanisms Cancer Research and Treatment Metal complexes synthesis and properties Diverse Scientific and Economic Studies Cancer, Hypoxia, and Metabolism Nanoparticle-Based Drug Delivery 14-3-3 protein interactions Curcumin's Biomedical Applications Computational Drug Discovery Methods Histone Deacetylase Inhibitors Research Click Chemistry and Applications Synthesis and Characterization of Heterocyclic Compounds Cancer Research and Treatments Cell death mechanisms and regulation Cancer Treatment and Pharmacology Estrogen and related hormone effects Cancer, Lipids, and Metabolism Natural product bioactivities and synthesis Synthesis of Organic Compounds Cancer, Stress, Anesthesia, and Immune Response Flavonoids in Medical Research Radiopharmaceutical Chemistry and Applications Bioactive Compounds and Antitumor Agents

Related Journals

TC
Thoracic Cancer WILEY
TI
Technology in Cancer Research & Treatment SAGE Publishing
CP
Cancer Pathogenesis and Therapy Elsevier BV
IJ
International Journal of Oncology Spandidos Publishing
CE
Cancer Epidemiology Biomarkers & Prevention American Association for Cancer Research
MO
Medical Oncology Springer Science+Business Media